There will be significant revenue growth this year as unrestricted European sales will become an option this quarter as will Limited US sales. What is interesting is that they already have 9 sales out of 500 they need for their unrestricted US sales even though they haven’t actually been able to sell anywhere of any population significance.
- Forums
- ASX - By Stock
- Ann: OncoSil FY21 half yearly review
There will be significant revenue growth this year as...
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.001(4.76%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $36.16K | 3.384M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 14154999 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 5667943 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 14004999 | 0.010 |
20 | 12071222 | 0.009 |
8 | 5387500 | 0.008 |
7 | 3264285 | 0.007 |
8 | 8595000 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 5667943 | 6 |
0.012 | 5912965 | 10 |
0.013 | 11057332 | 6 |
0.014 | 5769139 | 8 |
0.015 | 8500000 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online